{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:35:50Z","timestamp":1784543750670,"version":"3.55.0"},"reference-count":110,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Immunosuppression is a key treatment strategy for aplastic anaemia (AA) and the related immune\u2010mediated bone marrow failure syndromes (BMFS). For the last 20\u2003years the standard immunosuppressive regimen for AA patients has been anti\u2010thymocyte globulin (ATG) plus ciclosporin A (CyA), which results in response rates ranging between 50% and 70%, and even higher overall survival. However, primary and secondary failures after immunosuppressive therapy remain frequent, and to date all attempts aiming to overcome this problem have been unfruitful. This article reviews the state of the art of current immunosuppressive therapies for AA, focusing on open questions linked to standard immunosuppressive treatment, and on experimental immunosuppressive strategies which could lead to future improvement of current treatments. Specific immunosuppressive strategies employed for other BMFS, such as lineage\u2010restricted marrow failures, myelodysplastic syndromes and large granular lymphocyte leukaemia\u2010associated cytopenias, are also briefly discussed.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2010.08439.x","type":"journal-article","created":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T07:43:49Z","timestamp":1291189429000},"page":"127-140","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Immunosuppressive therapies in the management of immune\u2010mediated marrow failures in adults: where we stand and where we are going"],"prefix":"10.1111","volume":"152","author":[{"given":"Antonio M.","family":"Risitano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01734.x"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161206775193046"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-0944-y"},{"key":"e_1_2_9_5_1","doi-asserted-by":"crossref","unstructured":"Bacigalupo A.(2007)Aplastic anemia: pathogenesis and treatment. Hematology American Society of Hematology Education Program 2007 23\u201328.","DOI":"10.1182\/asheducation-2007.1.23"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb04645.x"},{"key":"e_1_2_9_7_1","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood.V95.6.1931","article-title":"Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony\u2010stimulating factor for severe aplastic anemia: an update of the GITMO\/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO)","volume":"95","author":"Bacigalupo A.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000041000"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2005.05.006"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.018267"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.006080"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.5061047.x"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199504270-00020"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.2.491.bloodjournal872491"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-225375"},{"key":"e_1_2_9_16_1","doi-asserted-by":"crossref","unstructured":"Calado R.T.(2009)Telomeres and marrow failure. Hematology American Society of Hematology Education Program 2009 338\u2013343.","DOI":"10.1182\/asheducation-2009.1.338"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-178871"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000040999"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.3.2.361"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198301203080301"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V66.1.184.184"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1620.bloodjournal8451620"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01693.x"},{"key":"e_1_2_9_24_1","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1182\/blood.V79.10.2566.2566","article-title":"Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high\u2010dose methylprednisolone, and oxymetholone","volume":"79","author":"Doney K.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.007815"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21886"},{"key":"e_1_2_9_27_1","first-page":"537","article-title":"Fontolizumab Protein Design Labs","volume":"6","author":"Dumont F.J.","year":"2005","journal-title":"Current Opinion in Investigational Drugs"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830250111"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402786"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105093241901"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1134"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12871"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb02817.x"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03947.x"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.2.483"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0816-5"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05406.x"},{"key":"e_1_2_9_38_1","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1182\/blood.V78.12.3209.3209","article-title":"Clonal hematopoiesis in patients with acquired aplastic anemia","volume":"78","author":"van Kamp H.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1988.tb04188.x"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.08.004"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0155"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2.4.431"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404747"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03574-1"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10075"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.7.2164.2164"},{"key":"e_1_2_9_47_1","doi-asserted-by":"crossref","unstructured":"Maciejewski J.P.&Risitano A.M.(2005)Aplastic anemia: management of adult patients. Hematology American Society of Hematology Education Program 2005 110\u2013117.","DOI":"10.1182\/asheducation-2005.1.110"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05277.x"},{"key":"e_1_2_9_49_1","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1182\/blood.V88.6.1983.bloodjournal8861983","article-title":"A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long\u2010term culture\u2010initiating cells) in acquired aplastic anemia","volume":"88","author":"Maciejewski J.P.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3513"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.9.3129"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03381.x"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1032"},{"key":"e_1_2_9_54_1","doi-asserted-by":"crossref","unstructured":"Marsh J.Making therapeutic decisions in adults with aplastic anemia. (2006) Hematology American Society Hematology Education Program 2006 78\u201385.","DOI":"10.1182\/asheducation-2006.1.78"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/0268-960X(88)90019-7"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07842.x"},{"key":"e_1_2_9_57_1","first-page":"595","article-title":"Treatment of bone marrow aplasia by mismatched bone marrow transplantation after conditioning with antilymphocyte globulin \u2013 long\u2010term results","volume":"8","author":"Math\u00e9 G.","year":"1976","journal-title":"Transplant Proceedings"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.006916"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.009191"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.10.3691"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-008-0125-0"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.3.1009"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22032"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb00230.x"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V68.3.712.712"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190410001723322"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0236"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16724-X"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.08027.x"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.11.3058.bloodjournal85113058"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.9.1130"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06903.x"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3325"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11192"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07216.x"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06098.x"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06085.x"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07450.x"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.13829"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.017889"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1376"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(98)00045-9"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(03)00008-0"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0035"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.7010"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.013557"},{"key":"e_1_2_9_87_1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1182\/blood.V66.3.721.721","article-title":"Specific antibody\u2010blocking activities in antilymphocyte globulin as correlates of efficacy for the treatment of aplastic anemia","volume":"66","author":"Smith A.G.","year":"1985","journal-title":"Blood"},{"key":"e_1_2_9_88_1","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/blood-2006-07-034272","article-title":"Granulocyte\u2010stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT)","volume":"109","author":"Socie G.","year":"2007","journal-title":"Blood"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199310143291603"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91537-9"},{"key":"e_1_2_9_91_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6267.860"},{"key":"e_1_2_9_92_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04148.x"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2485"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.1.703"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-050526"},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(72)90292-9"},{"key":"e_1_2_9_97_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00578.x"},{"key":"e_1_2_9_98_1","doi-asserted-by":"crossref","first-page":"496a","DOI":"10.1182\/blood.V114.22.496.496","article-title":"Use of G\u2010CSF in patients with severe aplastic anemia treated with atg and cyclosporine increases neutrophils and decreases infection rates and hospitalization days but does not improve long\u2010term outcome: results of a prospective, randomized clinical trial of the EBMT","volume":"114","author":"Tichelli A.","year":"2009","journal-title":"Blood"},{"key":"e_1_2_9_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03126-3"},{"key":"e_1_2_9_100_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0494"},{"key":"e_1_2_9_101_1","doi-asserted-by":"crossref","first-page":"3194a","DOI":"10.1182\/blood.V114.22.3194.3194","article-title":"Comparison between lymphoglobuline\u2010 and thymoglobuline\u2010based immunosuppressive therapy as first\u2010line treatment for patients with aplastic anemia","volume":"114","author":"Vallejo C.","year":"2009","journal-title":"Blood"},{"key":"e_1_2_9_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705894"},{"key":"e_1_2_9_103_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03039.x"},{"key":"e_1_2_9_104_1","first-page":"1","volume-title":"Bone Marrow Failure Syndromes","author":"Young N.S.","year":"2000"},{"key":"e_1_2_9_105_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199705083361906"},{"key":"e_1_2_9_106_1","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1182\/blood.V72.6.1861.1861","article-title":"A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases","volume":"72","author":"Young N.","year":"1988","journal-title":"Blood"},{"key":"e_1_2_9_107_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-010777"},{"key":"e_1_2_9_108_1","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1182\/blood.V93.9.3008.409a10_3008_3016","article-title":"Characterization of T\u2010cell repertoire of the bone marrow in immune\u2010mediated aplastic anemia: evidence for the involvement of antigen\u2010driven T\u2010cell response in cyclosporine\u2010dependent aplastic anemia","volume":"93","author":"Zeng W.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_9_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2006.03.017"},{"key":"e_1_2_9_110_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198501313120501"},{"key":"e_1_2_9_111_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.1.188"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2010.08439.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2010.08439.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T21:44:57Z","timestamp":1697406297000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2010.08439.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":110,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1111\/j.1365-2141.2010.08439.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08439.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"2010-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}